title: [Prevention of postoperative nausea and vomiting after hysterectomy with oral dolasetron, intravenous dehydrobenzperidol or a combination of both substances].
abstract: OBJECTIVE
  PONV is a frequent postoperative complication. The aim of this study was to assess the efficacy of oral dolasetron in comparison to intravenous droperidol (DHB) and to a combination of both drugs for prophylaxis of PONV.
  
  
  METHODS
  80 patients (ASA I-III) were randomly allocated to one of four groups and received the following medication: group A: 50 mg dolasetron was given orally 45-60 minutes before anaesthesia was induced, group B: 2.5 mg i.v. DHB + placebo p.o. was administered while inducing anaesthesia (positive control group), group C: 50 mg dolasetron was given 45-60 minutes before anaesthesia was induced and 2.5 mg i.v. DHB was given while inducing anaesthesia, group D: placebo tablet was administered 45-60 minutes before anaesthesia was induced (negative control group). PONV was assessed using a 5-point score: 0 = no symptoms, 1 = nausea, 2 = retching, 3 = vomiting, 4 = multiple vomiting. Metoclopramid was given as antiemetic if a patient reached two or more score points.
  
  
  RESULTS
  PONV scores were significantly lower in group A and C (p < 0.001) compared to the control group. Patients treated with DHB showed a significantly lower PONV score in comparison to the placebo treated patients (p < 0.05). Between the groups A, B and C we found no significantly different PONV scores. Postoperative consumption of metoclopramid was significantly lower in the groups A (2.4 +/- 5.2 mg) and C (1.0 +/- 3.1 mg) than in the placebo group (6.0 +/- 6.8 mg), whereas between group B (3.0 +/- 5.7 mg) and D we found no significant differences.
  
  
  CONCLUSIONS
  Single dose of oral dolasetron and single dose of intravenous DHB reduced PONV effectively, in patients undergoing gynaecologic surgery. A combination of dolasetron and DHB has no better effect than a single dose of oral dolasetron. Contrary to DHB the application of dolasetron decreased the postoperative antiemetic requirement significantly.
authors.affiliation: Klinik für Anästhesiologie und Operative Intensivmedizin, Klinikum der Stadt Ludwigshafen.
authors.forename: J G
authors.initials: JG
authors.lastname: Triem
authors.forename: S N
authors.initials: SN
authors.lastname: Piper
authors.forename: W H
authors.initials: WH
authors.lastname: Maleck
authors.forename: A
authors.initials: A
authors.lastname: Schenck
authors.forename: C C
authors.initials: CC
authors.lastname: Schmidt
authors.forename: J
authors.initials: J
authors.lastname: Boldt
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D004329:Droperidol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007211:Indoles / Q000627:therapeutic use*; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011807:Quinolizines / Q000627:therapeutic use*
chemical_list: D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; C060344:dolasetron; D008787:Metoclopramide; D004329:Droperidol
vernacular_title: Prophylaxe von postoperativer Ubelkeit und Erbrechen nach Hysterektomie mit oralem Dolasetron, intravenösem Dehydrobenzperidol (DHB) oder einer Kombination beider Substanzen. Eine placebokontrollierte Untersuchung.